Hints and tips:
Related Special Reports
...“They can go to [the] website, they can get the information they need, they can be linked to a prescriber and then a pharmacy, and do all those things independent of a primary care provider.”...
...The figures underscore a slow but steady shift by the taxpayer-funded NHS towards paying private providers for medical treatment, which health leaders say threatens the long-term financial viability of the...
...Lenders usually pay providers upfront for the cost of treatment, charging them for the financing costs....
...Spire has been expanding in complementary services and in October paid £74mn for Vita Health Group, a mental health provider....
...Getinge: The Swedish medical technology company opened 8.7 per cent down this morning in its first trading session since the US Food and Drug Administration urged providers to move away from the company’...
...It is the industry’s biggest source of sales, with projected 2028 revenues of $440bn, says data provider IQVIA....
...private providers that tracks treatment data....
...policy at the Center for Global Development think-tank in Washington.Yet Modi’s shift to expand insurance to cover private care for poor Indians “is not a panacea” and is “enormously complicated”, Jain said...
...The February cyber attack has caused havoc for medical payments at the largest clearinghouse for medical claims in the US....
...But the truth is, there is a difference in how men and women are supported by healthcare systems and providers....
...Amazon, which paid $3.9bn for One Medical in 2022, is an obvious future competitor but so too are big retailers such as Walmart. Early-stage investors are increasingly leery....
...healthcare providers”....
...While UK business groups say employers are increasingly concerned about the rising cost of medical cover for their staff as NHS waiting lists push people towards private healthcare, long Covid does not loom...
...medical insurance-funded services is ‘very positive’ or ‘positive’ so independent providers are upbeat about the[ir] prospects.”...
...Johnson Matthey: Shares in the London-listed chemicals producer were up 8 per cent after the company said it was selling its medical device components business to Montagu Private Equity for $700mn....
...Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to...
...For the biggest providers, there is an acceptance that prices will have to increase, both as a result of rising medical bills and doctor rates, but also spending to enhance customer infrastructure....
...Amazon Prime members will be able to access US healthcare provider One Medical’s suite of benefits, for a fee, as the ecommerce company looks to expand its presence in the $4tn American healthcare industry...
...Private providers such as Optegra are stepping up to make this necessary capital investment. We recently opened five NHS ophthalmic clinics, with several more planned for 2024....
...After a consultation with Flow Integrative, a ketamine therapy provider, the service was overseen by Enthea, a health insurance administrator that offers employers psychedelic treatment for staff....
...Mary Rasenberger, chief executive of the Authors Guild, points out that OpenAI is already negotiating licences with news providers. She says it “has plenty of money” to license books....
...This may well have been the basis upon which the other providers paid the benefits to your mother....
...Sir Julian Hartley, chief executive of NHS Providers, which represents health organisations across England, said the BMA’s decision was “another body blow for leaders of NHS services already stretched to...
...Industry specialists report that some criminals now steal, rather than encrypt, highly sensitive medical data and threaten to publish it on the dark web, unless the healthcare provider or patient pays a...
...Although the 21.1 per cent uptake of the GSK and Pfizer jabs is comfortably ahead of the 18 per cent forecast by health data provider Airfinity, GSK’s Arexvy jab has accounted for more than two-thirds of...
International Edition